Are National Comprehensive Cancer Network Evidence Block Affordability Ratings Representative of Real-World Costs? An Evaluation of Advanced Non-Small-Cell Lung Cancer.

CONCLUSION: Real-world aNSCLC treatment costs are often inconsistent with the NCCN ARs. Given that NCCN Evidence Blocks are intended to inform provider-patient discussions and other decision support resources, such as the NCCN Categories of Preference, our results suggest that the NCCN ARs require further refinement and validation.
PMID: 31513478 [PubMed - as supplied by publisher]

Source: JOP - September 11, 2019 Category: Gastroenterology Authors: Cohen JT, Lin PJ, Sheinson DM, Wong WB, Wu N, Yim YM, Ramsey SD Tags: J Oncol Pract Source Type: research